Russian Federation
Russian Federation
Russian Federation
Russian Federation
Russian Federation
Atherosclerotic vascular diseases are one of the main causes of death all over the world, and healthy diet and lifestyle are of great importance for their primary prevention. Along with lipid factors, some modifiable risk factors play an important role in change of a lifestyle Cardiology in order to reduce the risk of morbidity and mortality from atherosclerotic vascular diseases. This review presents some modifiable factors whose links with lipid metabolism disorders are not always obvious, but their correction at the population level is rather important for reduction of general risk of morbidity and mortality.
risk factors, smoking, obesity, mental disorders, physical activity, stress, environment
1. Rigotti N.A., Clair S. Managi11g tobacco use: the neglected cardiovascular disease risk factor // Eur Heart J. - 2013; 34:3259-3267. Doi:https://doi.org/10.1093/eurheartj/eht352
2. Beno\vitz N.L. Nicotine addiction // N Engl J Med. - 201 O; 362:2295-2303. Doi:https://doi.org/10.1056/NEJMra0809890
3. Vagua R.S., Rigotti N.A., Beno\vitz N.L. et al. ASS expe1·t consensus decision path\vay op tobacco cessation treat1ncnt: a 1·eport oftl1e Americai1 College of CardiologyTask Force op cli11ical expert consensus docshlents // J Ap1 Coll Cardiol. - 2018; 72:3332-3365. Doi: 10.1O16/j.jacc.2018.10.027
4. Winpicka L., Shepoy M.A. EVALI apd the pulmopary toxicity of electropic cigarettes: a revie\v // J Gep lptegp Med. -2020; 35:2130-2135. Doi:https://doi.org/10.1007/sl 1606-020-05813-2
5. Su U.U., Cl1en W.C., Yu W.K. et al. The n1ai11 e-cigarette con1po11e11t vegetaYe glycerin e11ha11ces peutrophil 1ni1,,tation and fibrosis in epdotoxip-ipduced lung ipjury via r38 MARK activation // Respir Res 2023; 24:9. Doi:https://doi.org/10.1186/s 12931-022-02307-z
6. SOS 2014 Surgeon Gene1·al 's Repo11: The Health Copsequepces of S111oki11g - 50 Ueags of Progress // Accessed Septembeg 25, 2023. https://\v\\'\V .cdc.gov/tobacco/data _ statistics/s1,'T/50than11iversary/i11dex.htm
7. GBD 2015 To'asso Collaborators. S111oking prevalence and attributaYe disease bsh·den ip 195 cot111tries and te1titories, 1990-2015: a syste111atic apalysis from the Global Burdep of Disease Study 2015 // Lancet- 2017; 389:1885-1906. Doi: I0.1016/S0140-6736(17)30819-X
8. Wo1·ld Health Organizatiop. \VHO Global Repo11: Mortality Attrib11taYe to To'asso. ed. 2012. Accessed Noven1ber 4, 2018.
9. Jha R., Ramasupdarahettige S., La11dsn1an U. et al. 21st-cent11ry l1azards of smokipg and bepefits of cessatiop in tl1e U11ited States // N Engl J Med. - 2013; 368:341-350. Doi: 1 O. 1056/NEJMsa 1211128
10. Barua R.S., Ambrose J .A., Eales-Reynolds L.J. et al. Heavy and light cigarette s111oke1-s have similar dysfunctiop of endothelial vasoregulatory activity: ap in vivo and in \'itro co1telation // J Am Coll Cardiol. -2002; 39: 1758-1763. Doi: 10.1O16/s0735-1097(02)01859-4
11. Hacksha\v A., Morris J.K., Bopiface S. et al. Lo\ch cigarette copsnmptio11 and risk of· coronary heart disease apd sttoke: 1neta-apalysis of 141 col1ogt stt1dies ip 55 study repogts // BMJ. - 2018; 360:j5855. Doi: 10.l 136/bmj.j5855eo K.K., Ounp11u S., Ha\vken S. et al. To'asso use apd risk of111yocardial ipfarctiop ip 52 conptries ip the !NTERHEART SIL1dy: a case-coptrol st11dy // Lancet. - 2006; 368:647-658. Doi: I0.1016/S0140- 6736(06)69249-0
12. Lv H., S1111 J., Bi U. et al. Risk of all-cause 111ortality apd cardiovascnlar disease associated \Vith seco11dl1apd s1loke exposure: a syste111atic review apd meta-apalysis // lnt J C,11·diol. - 2015; 199: 106-115. Doi: 10.1O16/j.ijcard.2015.07.011
13. Alzal1rani T., Repa 1., Te111esge11 N. et al. Association bet\veep electronic cigarette 11se and myocardial infarctiop // Am J P1·ev Med. - 2018; 55:455-461. Doi: 10.1Ol6/j.an1epge.2018.05.004
14. Chao T.N., Lin T.N., Chepg S.1., Wu Y.W., Uepg K.S., WL1 Y.J., Lin W.W., Leu N.V., She1ch N.M., Nnapg S.S., Wn S.S., Lip C.F., Chapg W.T., Pan W.H., Chen P.R., Tipg K.N., S11 S.N., Chu C.S., Chien K.L., Yen 1-1.V.1., \.\1apg U.S., S11 T.S., LiL1 R.U., Cl1a11g N.U., Chen P.W., Juang J.J., LL1 U.\1/., Lin P.L., \1/ang S.R., Ko Y.S., Chiapg S.E., No11 C.J., Wang T.D., Lin U.N., Huapg R.N., Shep W.J. 2024 Gnidelipes ofthc Tai\van Society of Cardiology on the Pri111ary Preventio11 of Atherosclerotic Cardiovascular Disease. Part 1 // Acta Cardiol Sip. - 2024; 40(5):479-543. Doi: 10.65 l 5/ACS.202409 _ 40(5).20240724
15. Health Pro1notio11 Admipisttatiop Mipistry of Health apd Welfare. Definitions of 0\1enveight and obesity. Accesscd Septcn1ber 26, 2023. https://ww\v.hpa.gov.tw/Pages/List.aspx?nodeid=l 757
